PT12220U - Seringa de dupla câmara - Google Patents
Seringa de dupla câmaraInfo
- Publication number
- PT12220U PT12220U PT12220U PT1222020U PT12220U PT 12220 U PT12220 U PT 12220U PT 12220 U PT12220 U PT 12220U PT 1222020 U PT1222020 U PT 1222020U PT 12220 U PT12220 U PT 12220U
- Authority
- PT
- Portugal
- Prior art keywords
- washing solution
- double chamber
- syringe
- independent
- medicine
- Prior art date
Links
- 238000011010 flushing procedure Methods 0.000 abstract 2
- 239000000470 constituent Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/19—Syringes having more than one chamber, e.g. including a manifold coupling two parallelly aligned syringes through separate channels to a common discharge assembly
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/28—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle
- A61M5/284—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle comprising means for injection of two or more media, e.g. by mixing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
Landscapes
- Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
A PRESENTE INVENÇÃO REFERE-SE A UMA SERINGA COM DUPLA CÂMARA (1), OU SEJA, COM DOIS COMPARTIMENTOS INDEPENDENTES COM SAÍDAS INDEPENDENTES, DOIS ÊMBOLOS INDEPENDENTES (2)(3) IMPEDINDO A MISTURA DE FLUIDOS. A PRESENTE INVENÇÃO SURGE DA NECESSIDADE DE UMA SERINGA PARA ADMINISTRAÇÃO ENDOVENOSA QUE POSSIBILITE SIMULTANEAMENTE, O CARREGAMENTO E A ADMINISTRAÇÃO SEQUENCIAL DE FÁRMACO E SOLUÇÃO DE LAVAGEM DO DISPOSITIVO MÉDICO ONDE FOI ADMINISTRADO O MEDICAMENTO. TODOS OS CONSTITUINTES ESTÃO CONFIGURADOS DE TAL FORMA QUE POSSIBILITAM A ADMINISTRAÇÃO SEQUENCIAL DE SOLUÇÃO DE LAVAGEM (PRÉ-FLUSHING), DO MEDICAMENTO E NOVAMENTE DA SOLUÇÃO DE LAVAGEM (FLUSHING FINAL).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PT12220U PT12220Y (pt) | 2020-07-01 | 2020-07-01 | Seringa de dupla câmara |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PT12220U PT12220Y (pt) | 2020-07-01 | 2020-07-01 | Seringa de dupla câmara |
Publications (2)
Publication Number | Publication Date |
---|---|
PT12220U true PT12220U (pt) | 2023-11-16 |
PT12220Y PT12220Y (pt) | 2024-01-30 |
Family
ID=89068973
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT12220U PT12220Y (pt) | 2020-07-01 | 2020-07-01 | Seringa de dupla câmara |
Country Status (1)
Country | Link |
---|---|
PT (1) | PT12220Y (pt) |
-
2020
- 2020-07-01 PT PT12220U patent/PT12220Y/pt active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
PT12220Y (pt) | 2024-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Pöpping et al. | Impact of epidural analgesia on mortality and morbidity after surgery: systematic review and meta-analysis of randomized controlled trials | |
Nguyen et al. | The safety of intra-articular injections for the treatment of knee osteoarthritis: a critical narrative review | |
Desousa | Pain on propofol injection: Causes and remedies | |
Mortensen et al. | Consensus guidelines for enhanced recovery after gastrectomy | |
Yaftali et al. | Corticosteroids and hyaluronic acid injections | |
Guenezan et al. | Chlorhexidine plus alcohol versus povidone iodine plus alcohol, combined or not with innovative devices, for prevention of short-term peripheral venous catheter infection and failure (CLEAN 3 study): an investigator-initiated, open-label, single centre, randomised-controlled, two-by-two factorial trial | |
Rutjes et al. | Viscosupplementation for osteoarthritis of the knee: a systematic review and meta-analysis | |
Bisicchia et al. | HYADD 4 versus methylprednisolone acetate in symptomatic knee osteoarthritis: a single-centre single blind prospective randomised controlled clinical study with 1-year follow-up | |
Vadhanan et al. | Physiological and pharmacologic aspects of peripheral nerve blocks | |
BR112022012637A2 (pt) | Composto de piridazinil-tiazolcarboxamida, composição farmacêutica e inibidor da dgk ¿ que compreendem o mesmo e uso do dito composto para tratar câncer relacionado à ativação das células imunes ou câncer tendo resistência à terapia com anticorpo anti-pd-1 / anticorpo anti-pd-l1 | |
BR112021017993A2 (pt) | Preparações de agente terapêutico e métodos para liberação de fármacos em um lúmen do trato intestinal com o uso de um dispositivo ingerível de liberação de fármacos | |
CL2022002084A1 (es) | Formulaciones farmacéuticas | |
Bagheri-Nesami et al. | The effects of sesame oil on the prevention of amiodarone-induced phlebitis | |
Baradari et al. | Effects of combined prokinetic administration on gastric emptying in critically ill patients | |
BR112022008000A2 (pt) | Derivado de pirazol-heteroarila, método de preparação para o mesmo e uso médico do mesmo | |
Noaparast et al. | Nicolau syndrome after intramuscular benzathine penicillin injection | |
Wojcikowski et al. | New Concepts of Chronic Pain and the Potential Role of Complementary Therapies. | |
PT12220U (pt) | Seringa de dupla câmara | |
Kanic et al. | GPIIb-IIIa receptor inhibitors in acute coronary syndrome patients presenting with cardiogenic shock and/or after cardiopulmonary resuscitation | |
Van Der Rijt et al. | Reversal of hand peripheral ischaemia due to extravasation of adrenaline during cardiopulmonary resuscitation | |
BR112022009510A2 (pt) | Análogo de insulina, composição farmacêutica, e, método de tratamento, prevenção ou alívio de uma doença ou distúrbio ou condição | |
Bedi et al. | Bleeding risk of dietary supplements: a hidden nightmare for cardiac surgeons | |
Dalkiran et al. | Phantom limb pain treated with duloxetine: a case series | |
BR112023024392A2 (pt) | Uso de uma formulação de combinação farmacêutica, uso de lipopeptídeos e poli(i:c), e pelo menos um ingrediente ativo adicional | |
Bravo et al. | Siliconoma: report of two cases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB1K | Laying open of utility model application |
Effective date: 20230630 |
|
FG3K | Utility model granted, date of granting |
Effective date: 20240125 |